Soluble interleukin 2 receptor in atopic eczema.
Data up to Jan 2025
Total Citations Per Year
Abstract
References (28)
Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro.
1985 • 1,143 citations
Interleukin-2 augments natural killer cell activity
1981 • 921 citations
Triggering of the T3-Ti antigen-receptor complex results in clonal T-cell proliferation through an interleukin 2-dependent autocrine pathway.
1984 • 506 citations
The interleukin 2 receptor. Functional consequences of its bimolecular structure.
1987 • 409 citations
Human interleukin-2 promotes proliferation of activated B cells via surface receptors similar to those of activated T cells
1984 • 375 citations
Cyclosporin A and dexamethasone suppress T cell responses by selectively acting at distinct sites of the triggering process.
1980 • 351 citations
The released interleukin 2 receptor binds interleukin 2 efficiently.
1986 • 348 citations
Recombinant interleukin-2 directly augments the cytotoxicity of human monocytes
1987 • 301 citations
Immunoglobulin E in Dermatoses
1969 • 298 citations
Soluble IL-2 receptor in rheumatoid arthritis. Correlation with disease activity, IL-1 and IL-2 inhibition.
1988 • 274 citations
Characterization of the human receptor for T-cell growth factor.
1983 • 240 citations
Depression of cell-mediated immunity in atopic eczema
1975 • 196 citations
Effect of cyclosporin A and dexamethasone on interleukin 2 receptor gene expression.
1986 • 171 citations
Soluble interleukin‐2 receptors in systemic lupus erythematosus
1988 • 170 citations
Structure-function relationships for the IL 2-receptor system. IV. Analysis of the sequence and ligand-binding properties of soluble Tac protein.
1987 • 165 citations
Flow cytometric resonance energy transfer measurements support the association of a 95-kDa peptide termed T27 with the 55-kDa Tac peptide.
1987 • 99 citations
Serum interleukin-2-receptor in rheumatoid arthritis: A prognostic indicator of disease activity?
1988 • 85 citations
Quantitative analysis of T-lymphocyte subsets in atopic eczema, using monoclonal antibodies and flow cytoafluorimetry
1983 • 65 citations
Predominance of T lymphocytes in the dermal infiltrate of atopic dermatitis
1979 • 65 citations
Immune status in atopic eczema: a survey
1979 • 63 citations
Interleukin 2 synthesis in the presence of steroids: a model of steroid resistance.
1987 • 58 citations
Corticosteroid-interleukin 2 interactions: inhibition of binding of interleukin 2 to interleukin 2 receptors.
1987 • 49 citations
Interleukin 2 receptor in patients with localized and systemic parasitic diseases.
1988 • 46 citations
Humoral and cellular immunity in children with active and quiescent atopic dermatitis
1987 • 32 citations
Interleukin 2 functions through novel interleukin 2 binding molecules in T cells.
1988 • 30 citations
Studies on hyperimmunoglobulinaemia E in atopic diseases with particular reference to food allergens.
1981 • 24 citations
Suppression of the local graft‐vs.‐host reaction in ratsby treatment with a monoclonal antibody specific for the interleukin 2 receptor
1986 • 18 citations
Determination of cell-free interleukin 2 receptor level in the serum of normal animals and of animals bearing IL-2 receptor positive tumours with high or low metastatic capacity
1987 • 13 citations
Cited By (0)
No citing papers found in database